Table 1 Patient and pathological characteristics, and engraftment of PDX of 12 endometrial cancer cases.

From: Alteration in molecular properties during establishment and passaging of endometrial carcinoma patient-derived xenografts

Case

Age

Diagnosis

Tumor grade

TNM, FIGO2008

Extra uterine metastasis

Engraftment of PDX

UXE-001

90

Endometrioid carcinoma, G1

G1

pT1aN0, IA

N

Yes

UXE-002

43

Endometrioid carcinoma, G1

G1

pT3aN0, IIIA

N

No

UXE-003

36

Endometrioid carcinoma, G1

G1

pT2N0, II

N

No

UXE-004

50

Carcinosarcoma, heterologous

High

pT1aN2, IIIC2

N

Yes

UXE-005

77

Mixed cell carcinoma (endometrioid G2 and serous)

G2/high

pT1bN0, IB

N

Yes

UXE-006

67

Endometrioid carcinoma, G1

G1

pT1aN0, IA

N

No

UXE-007

48

Endometrioid carcinoma, G1

G1

pT1aN0, IA

N

No

UXE-008

70

Carcinosarcoma, homologous

High

pT2N0, II

N

Yes

UXE-009

46

Carcinosarcoma, heterologous

High

pT3aN2, IIIC2

Ovary, para-aortic node

Yes

UXE-010

52

Endometrioid carcinoma, G1

G1

pT1bN0, IB

N

Yes

UXE-011

64

Endometrioid carcinoma, G3

G3

pT1aN1, IIIC1

N

No

UXE-012

63

Endometrioid carcinoma, G3

G3

pT3aN1M1, IVB

Peritoneal dissemination

No

  1. G1 grade 1, G3 grade 3, high high-grade, N none.